Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Optic Neuritis, Demyelinating Disease”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Not applicableUnknownNCT03370965
What this trial is testing

Optic Neuritis Differential Diagnosis Study

Who this might be right for
Optic NeuritisNeuromyelitis OpticaMultiple Sclerosis
University Hospital Center of Martinique 150
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Not applicableStudy completedNCT03451955
What this trial is testing

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Who this might be right for
Optic NeuritisMultiple SclerosisClinically Isolated Syndrome
University of Copenhagen 103
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Not applicableLooking for participantsNCT06389968
What this trial is testing

Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingOptic Neuritis
Technical University of Munich 50
Very early researchNot Yet RecruitingNCT06485232
What this trial is testing

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple Sclerosis+1 more
Xuanwu Hospital, Beijing 25
Testing effectiveness (Phase 2)Study completedNCT00355095
What this trial is testing

Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis

Who this might be right for
Optic Neuritis
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Testing effectiveness (Phase 2)Study completedNCT01274702
What this trial is testing

Visual Reconstitution Therapy After Optic Neuritis

Who this might be right for
Optic NeuritisMultiple Sclerosis
Friedemann Paul 25
Not applicableStudy completedNCT01774123
What this trial is testing

Optical Coherence Tomography in Multiple Sclerosis Patients

Who this might be right for
Multiple SclerosisOptic Neuritis
The Cleveland Clinic 78
Early research (Phase 1)Not Yet RecruitingNCT07341828
What this trial is testing

C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more
Huashan Hospital 15
Testing effectiveness (Phase 2)UnknownNCT01364246
What this trial is testing

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica

Who this might be right for
Progressive Multiple SclerosisNeuromyelitis Optica.
Shenzhen Beike Bio-Technology Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT01337986
What this trial is testing

Ampyra for Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple SclerosisOptic Neuritis
Washington University School of Medicine 53
Post-approval studies (Phase 4)Ended earlyNCT01838174
What this trial is testing

A Trial of Neuroprotection With ACTH in Acute Optic Neuritis

Who this might be right for
Multiple Sclerosis
University of Colorado, Denver 37
Not applicableUnknownNCT01024985
What this trial is testing

Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
University of Sao Paulo 40
Very early researchNot Yet RecruitingNCT07392528
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMultiple SclerosisMyasthenia Gravis
Tianjin Huanhu Hospital 15
Not applicableLooking for participantsNCT07202494
What this trial is testing

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)+7 more
Assistance Publique Hopitaux De Marseille 700
Not applicableLooking for participantsNCT06494228
What this trial is testing

Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis

Who this might be right for
Multiple SclerosisDemyelinating Diseases
University Hospital, Strasbourg, France 60
Large-scale testing (Phase 3)Study completedNCT01962571
What this trial is testing

Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

Who this might be right for
Optic Neuritis
University Eye Hospital, Freiburg 108
Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Not applicableStudy completedNCT03651362
What this trial is testing

Linking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis

Who this might be right for
Optic Neuritis
University Hospital, Lille 46
Load More Results